Tendon Repair Articles & Analysis
18 news found
About RepliCel Life Sciences RepliCel is a regenerative medicine company focused on developing cell therapies for aesthetic and orthopedic conditions affecting what the Company believes is approximately one in three people in industrialized nations, including aging/sun-damaged skin, pattern baldness, and chronic tendon degeneration. These conditions, often associated with aging, ...
About RepliCel Life Sciences RepliCel is a regenerative medicine company focused on developing cell therapies for aesthetic and orthopedic conditions affecting what the Company believes is approximately one in three people in industrialized nations, including aging/sun-damaged skin, pattern baldness, and chronic tendon degeneration. These conditions, often associated with aging, ...
The DermaPrecise injection system is supplied with single-use cartridges and multi-needle heads for use with injectables of varying viscosity including highly viscose products such as some of the newer crosslinked hyaluronic acid-based dermal fillers and antibody therapeutics. About RepliCel's Skin and Tendon Programs RepliCel is currently preparing for the clinical testing and ...
About RepliCel Life Sciences RepliCel is a regenerative medicine company focused on developing cell therapies for aesthetic and orthopedic conditions affecting what the Company believes is approximately one in three people in industrialized nations, including aging/sun-damaged skin, pattern baldness, and chronic tendon degeneration. These conditions, often associated with aging, ...
About RepliCel Life Sciences RepliCel is a regenerative medicine company focused on developing cell therapies for aesthetic and orthopedic conditions affecting what the Company believes is approximately one in three people in industrialized nations, including aging/sun-damaged skin, pattern baldness, and chronic tendon degeneration. These conditions, often associated with aging, ...
These include two cell therapies - one for skin rejuvenation and one for tendon regeneration - and a next-generation dermal injector (DermaPrecise™) for aesthetic treatments involving a wide variety of injectable substances including cells, PRP, muscle paralysis toxins, fillers, enzymes, drugs, and other biologics. ...
Surgical procedures included amputation, removal of exostosis, midfoot bone removal, Achilles’ tendon repair, bunionectomy, or an elevating osteotomy with primary closure of the wound. ...
InGeneron, Inc., a clinical stage regenerative medicine and cell therapy company, today announced the publication of the first-in-human comprehensive immunohistochemical evaluation of adult tendon repair following the local injection of fresh, uncultured, unmodified, autologous, adipose derived regenerative cells (UA-ADRCs). This newly-released research paper, ...
“We expect BioBrace to be a game-changing technology for surgeons seeking to augment their repairs mechanically and biologically,” said Kevin Rocco, Biorez founder and CEO. ...
(www.conextionsmed.com), an innovator in tendon repair, announced today the first patient has been treated with the Coronet Soft Tissue Fixation System in a Kidner procedure. The Kidner procedure is the most common surgical treatment for a painful accessory navicular bone that causes foot/tendon pain. The Coronet Soft Tissue Fixation Systems is a ...
The Coronet’s novel design improves the soft tissue fixation strength of these repairs compared to conventional suture repairs. A streamlined delivery system allows for the simultaneous placement of the implant in the bone and soft tissue and provides a knotless repair. ...
A 17-year-old male patient with a severed extensor tendon of his thumb due to traumatic injury became the first outside of a clinical trial to undergo tendon repair with CoNextions Medical’s TR Tendon Repair device since the product’s recent approval in Chile, the first country to approve the device. ...
CoNextions Medical, a developer of novel soft tissue repair devices, announced today that it has completed enrollment in a key clinical trial for its pioneering tendon-to-tendon repair device, CoNextions TR. ...
(www.conextionsmed.com) announced today that its has enrolled its first two patients in a multicenter, blinded, randomized clinical trial comparing the CoNextions TR System to standard of care suture repair for repair of Zone 2 tendon lacerations. The first two patients were enrolled at Groote Schuur Hospital in Cape Town, South Africa. ...
Poka’s first-hand experience in caring for injured patients will be invaluable as we maintain our focus on the achievement of our mission to dramatically improve patient outcomes, reduce surgical complications, improve the quality of life for patients, and improve the health economics of tendon repair worldwide.” Dr. Poka said, “I am honored to ...
” Dan Gruppo stated, “It is never easy to leave a large company with a track record of success, such as Stryker, but after meeting the people at CoNextions Medical and seeing the CoNextions TR™ tendon approximation and soft tissue repair system and their future pipeline, it was clear that I had to join the team. The soft tissue ...
In 2011, Erik Kubiak, M.D., an orthopaedic trauma and adult reconstruction surgeon and Associate Professor of Orthopaedic Surgery at the University of Utah, co-founded CoNextions Medical to treat tendon repairs differently than traditional, suture-based methods. Earlier this year, the company received the Utah Innovation Award in the Life Sciences – ...
“For decades, surgeons have repaired tendons with suture-based techniques that are complex and yield unpredictable outcomes,” said Richard J. ...